What medical and pharmaceutical/bioscience/medical device meeting planners and continuing medical education professionals need to know to plan meetings and CME activities for healthcare professionals.
Check it out: CME Linkages, written by CME consultant Debra Gist. I think it's off to a great start, with several intriguing posts. Can't wait to see what she does with it.
According to this article in the Boston Globe, there's a Web site that allows doctors to post their experiences with various drugs, therapies, and instruments. It sounds sort of like a TripAdvisor, only for the healthcare industry instead of the...
Are you curious about lessons learned from the Neurontin case? If so, don't miss "Interview with Dr. Michael A. Steinman, M.D.," a new podcast available at Medical Science Liaison Resource Portal, run by Jane Chin. Here's the synopsis from the...
From Anne Taylor-Vaisey:
Here is a "perspective" just published online in the New England Journal of Medicine, as well as links to the IOM's publication on drug safety.
Read about new articles on physicians and the pharmaceutical industry on Anne Taylor-Vaisey's blog here. She also has updated her "New in the Medical Education Journals page," with a new issue on Innovations in Problem-based Learning, available...
Is anyone else going to the National Task Force on CME Provider/Industry Collaboration meeting in Baltimore this month? If so, I hope to run into you there. This year, it could be even more interesting than usual!
According to the Sacramento Bee, the University of California at Davis is thinking about joining Stanford and Yale in imposing "strict limits on meals and on payments for doctors to attend meetings or participate in online medical education...
Do we really need CME on what doctors should tell patients about the drugs they prescribe? According to this study, I'm guessing the answer is "yes." From the New York Times writeup of the study...
